Pharmaron Beijing Co., Ltd. Stock price

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
20.43 CNY +1.14% Intraday chart for Pharmaron Beijing Co., Ltd. -8.59% -29.50%
Sales 2024 * 12.77B 1.77B Sales 2025 * 15.63B 2.16B Capitalization 33.02B 4.57B
Net income 2024 * 1.65B 229M Net income 2025 * 2.28B 315M EV / Sales 2024 * 2.9 x
Net Debt 2024 * 4.01B 555M Net Debt 2025 * 2.6B 360M EV / Sales 2025 * 2.28 x
P/E ratio 2024 *
21.5 x
P/E ratio 2025 *
16.5 x
Employees -
Yield 2024 *
0.96%
Yield 2025 *
1.26%
Free-Float 51.02%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.14%
1 week-8.59%
Current month-12.51%
1 month-9.24%
3 months-29.60%
6 months-34.31%
Current year-29.50%
More quotes
1 week
20.05
Extreme 20.05
22.47
1 month
20.05
Extreme 20.05
25.80
Current year
18.50
Extreme 18.5
28.90
1 year
18.50
Extreme 18.5
39.25
3 years
18.50
Extreme 18.5
108.71
5 years
13.85
Extreme 13.8489
108.71
10 years
4.08
Extreme 4.0844
108.71
More quotes
Managers TitleAgeSince
Founder 56 04-06-30
Founder 56 04-06-30
Chief Executive Officer 60 04-06-30
Members of the board TitleAgeSince
Director/Board Member 59 19-08-14
Chief Executive Officer 60 04-06-30
Founder 56 04-06-30
More insiders
Date Price Change Volume
24-03-28 20.43 +1.14% 25,189,330
24-03-27 20.2 -3.07% 27,024,240
24-03-26 20.84 -1.28% 25,025,070
24-03-25 21.11 -0.75% 36,097,260
24-03-22 21.27 -4.83% 32,799,270

End-of-day quote Shenzhen S.E., March 27, 2024

More quotes
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows: - laboratory services (61.3%); - development and production of chemical processes and formulations (23.5%); - clinical research services (12.8%); - other (2.4%); Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
20.43 CNY
Average target price
31.31 CNY
Spread / Average Target
+53.27%
Consensus
  1. Stock
  2. Equities
  3. Stock Pharmaron Beijing Co., Ltd. - Shenzhen S.E.